期刊文献+

CD4^+CD25^+调节性T细胞对慢性丙型肝炎患者病毒特异性CD8^+T细胞的抑制作用 被引量:8

原文传递
导出
摘要 HCV感染是严重危害人民健康的传染病,易发展成慢性丙型肝炎、肝硬化,且与原发性肝癌密切相关。HCV持续感染的一个重要原因是HCV特异性CD8^+T细胞数量及功能缺陷,表现在体外增殖能力下降和IFN-γ分泌水平降低。CD4^+CD25^+调节性T细胞(T regulatory cells,Treg)主要在机体免疫系统中发挥负向调节作用,在移植物抗宿主病、自身免疫病、过敏性疾病等的发病机制和临床治疗中有潜在应用价值。已有研究表明,
出处 《中华传染病杂志》 CAS CSCD 北大核心 2007年第5期309-311,共3页 Chinese Journal of Infectious Diseases
  • 相关文献

参考文献12

  • 1Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature, 2005, 436: 946-952.
  • 2Rushbrook SM, Ward SM, Unitt E, et al. Regulatory T cells suppress in vitro proliferation of virus-specific CD8^+ T cells during persistent hepatitis C virus infection. J Virol, 2005, 79:7852-7859.
  • 3丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 4谭建明,唐孝达,谢桐,徐琴君,丁言德.人类白细胞抗原-Ⅰ类抗原的DNA分型与临床应用[J].中华医学杂志,1998,78(10):763-767. 被引量:13
  • 5刘海鹰,周玲,曾毅.检测Epstein-Barr病毒特异性细胞毒性T淋巴细胞方法的建立及其初步研究[J].中华实验和临床病毒学杂志,1998,12(4):357-360. 被引量:8
  • 6Lechner F, Gruener NH, Urbani S, et al. CD8^+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol, 2000, 30: 2479- 2487.
  • 7Boettler T, Spangenberg HC, Neumann-Haefelin C, et al. t cells with a CD4^+ CD25^+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8^+ T cells during chronic hepatitis C virus infection. J Virol, 2005, 79:7860-7867.
  • 8Aandahl EM, Michaelsson J, Moretto WJ, et al. Human CD4^+ CD25^+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol, 2004, 78:2454-2459.
  • 9Lucas M, Vargas-Cuero AL, Larer GM, et al. Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8^+ T cells. J Immunol, 2004, 172:1744-1753.
  • 10Sugimoto K, Ikeda F, Stadanlick J, et al. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology, 2003, 38:1437-1448.

二级参考文献38

  • 1段学章,李捍卫,王敏,王福生.乙型肝炎病毒感染者树突状细胞(DC)亚群的变化及意义[J].中华微生物学和免疫学杂志,2004,24(11):892-896. 被引量:12
  • 2范振平,王福生,徐东平,褚福亮,施明,周宇,张玲霞.乙型肝炎患者HBcAg特异性细胞毒性T细胞的检测及其与临床疾病状态的关系[J].中华医学杂志,2004,84(24):2073-2076. 被引量:18
  • 3王福生.天然免疫应答清除HBV的作用及其临床免疫治疗的前景[J].中华医学杂志,2005,85(17):1158-1159. 被引量:6
  • 4Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 5Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 6Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 7Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 8Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 9Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 10Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.

共引文献778

同被引文献75

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部